Itziar Canamasas's Colleagues at ALX Oncology
Itziar Canamasas's Contact Details
HQ
["(353) 161-8000"]
["(353) 161-8000"]
Location
Basel,Basel-Stadt,Switzerland
Basel,Basel-Stadt,Switzerland
Company
ALX Oncology
ALX Oncology
Itziar Canamasas's Company Details
ALX Oncology is a publicly traded, clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system. ALX Oncology's lead product candidate, evorpacept (also known as ALX148), is a next generation CD47 blocking therapeutic that combines a high-affinity CD47 binding domain with an inactivated, proprietary Fc domain. Evorpacept has demonstrated promising clinical responses across a range of hematologic and solid malignancies in combination with a number of leading anti-cancer agents.
Frequently Asked Questions about Itziar Canamasas
Itziar Canamasas currently works for ALX Oncology.
Itziar Canamasas's role at ALX Oncology is Member Board Of Directors.
Itziar Canamasas's email address is ***@bayer.com. To view Itziar Canamasas's full email address, please signup to ConnectPlex.
Itziar Canamasas works in the Research industry.
Itziar Canamasas's colleagues at ALX Oncology are Julie Bacon, Andrew Olson, Adela Hasa-Moreno, Connie Lu, Michael Chang, Steffen P., Hank Stern and others.
Itziar Canamasas's phone number is ["(353) 161-8000"]